1. Home
  2. MMLP vs ICCC Comparison

MMLP vs ICCC Comparison

Compare MMLP & ICCC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Martin Midstream Partners L.P. Limited Partnership

MMLP

Martin Midstream Partners L.P. Limited Partnership

HOLD

Current Price

$2.10

Market Cap

90.8M

Sector

Energy

ML Signal

HOLD

Logo ImmuCell Corporation

ICCC

ImmuCell Corporation

N/A

Current Price

$9.77

Market Cap

75.8M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
MMLP
ICCC
Founded
2002
1982
Country
United States
United States
Employees
N/A
N/A
Industry
Oil Refining/Marketing
Biotechnology: Pharmaceutical Preparations
Sector
Energy
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
90.8M
75.8M
IPO Year
2002
1995

Fundamental Metrics

Financial Performance
Metric
MMLP
ICCC
Price
$2.10
$9.77
Analyst Decision
Hold
Analyst Count
1
0
Target Price
$3.00
N/A
AVG Volume (30 Days)
46.7K
21.8K
Earning Date
04-22-2026
05-15-2026
Dividend Yield
0.78%
N/A
EPS Growth
N/A
53.85
EPS
N/A
0.21
Revenue
$1,653,009,000.00
$26,493,169.00
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
$46.98
Revenue Growth
0.65
51.64
52 Week Low
$1.89
$4.52
52 Week High
$3.54
$10.75

Technical Indicators

Market Signals
Indicator
MMLP
ICCC
Relative Strength Index (RSI) 36.10 56.52
Support Level N/A $9.29
Resistance Level $2.83 $10.75
Average True Range (ATR) 0.23 0.31
MACD -0.05 -0.06
Stochastic Oscillator 26.13 61.11

Price Performance

Historical Comparison
MMLP
ICCC

About MMLP Martin Midstream Partners L.P. Limited Partnership

Martin Midstream Partners LP has a diverse set of operations focused on the United States Gulf Coast region. The company's business lines include terminalling, processing, storage, and packaging services for petroleum products and by-products, including the refining of naphthenic crude oil; land and marine transportation services for petroleum products and by-products, chemicals, and specialty products; sulfur and sulfur-based products processing, manufacturing, marketing, and distribution; and natural gas liquids marketing, distribution and transportation services. The company operates in four segment Terminalling and storage, Transportation, Sulfur service, and Specialty products segment. The majority of the revenue is derived from the Specialty products segment.

About ICCC ImmuCell Corporation

ImmuCell Corp is an animal health biologics company focused on the development, manufacture, and commercialization of products intended to improve the survivability, health, and long-term performance of neonatal dairy and beef calves. Its product, First Defense, utilizes hyperimmunized bovine colostrum to provide pathogen-specific antibodies and other bioactive components. First Defense is designed to provide Immediate Immunity through orally delivered antibodies against the principal viral and bacterial causes of neonatal calf diarrhea (scours), including Escherichia coli (E.coli), bovine coronavirus, and bovine rotavirus. It has two operating segments: Scours and Mastitis. It derives the majority of the revenue from the Scours segment that consists of the First Defense product line.

Share on Social Networks: